Robert Hureau Joins PPD
News Aug 28, 2014
Pharmaceutical Product Development, LLC (PPD) has announced the appointment of Robert Hureau as executive vice president and chief financial officer.
Hureau brings 25 years of experience and extensive financial expertise spanning the medical technology/life sciences, manufacturing and consumer sectors. Hureau begins his new role on Sept. 23 and will be based in PPD’s headquarters in Wilmington.
“Bob is an accomplished chief financial officer who will uphold PPD’s long-standing reputation as a company committed to integrity, financial discipline and sustainable growth,” said David Simmons, PPD’s chairman and chief executive officer. “We are confident Bob’s experience, strong business mind and financial acumen will complement and aid PPD's focus on delivering value for our biopharmaceutical clients.”
Hureau joined PPD from Centaur Guernsey L.P. Inc., a leading global medical technology company focused on transformational healing solutions, where he served as executive vice president and CFO.
Previously, he held a series of senior leadership positions of increasing responsibility, including senior vice president and CFO at Sensata Technologies N.V., a supplier of sensing, electrical protection, control and power management solutions, and vice president of finance with The Jean Coutu Group (PJC) U.S.A., Inc., chain of retail pharmacies.
In addition, Hureau’s experience includes financial leadership responsibilities with Ocean Spray Cranberries, Inc., and other companies in the consumer sector. Hureau is a certified public accountant and began his career at Coopers & Lybrand.
Scientists Report The Development of a Potent New Medicine to Fight AddictionNews
Scientists report the development of a potent new medicine to fight addiction.READ MORE
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Lonza Expands Encapsulation and HPAPI Capabilities in North AmericaNews
Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.READ MORE